Pfizer headquarters in New York.Getty ImagesPfizer and Germany’s BioNTech announced on Wednesday that they would develop a potential mRNA-based vaccine for the prevention of viral shingles, working together for the third time after the success of… Click below to read the full story from TechCrunch
Read More
Pfizer, BioNTech to jointly develop shingles vaccine
